India's Supreme Court mulls challenge to generic-friendly patent law

01/23/2013 | Scienceline

The Indian Supreme Court is weighing the importance of protecting pharmaceutical innovation and providing affordable access to drugs after the country's generic-friendly patent law was challenged by a drugmaker's appeal concerning a cancer treatment. "The whole case is about encouraging generics and the central role they have had in treating deadly diseases," said Patricia Kahn of Medecins Sans Frontieres. Representatives of the pharmaceutical industry disagree, saying patents protect innovation and invention.

View Full Article in:

Scienceline

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA